TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
ARGX

argenx NV

Healthcare · Biotechnology

851.30$ -0.7% vs. previous close Closing price · As of: Aug 14, 2026

Statements

Cash Flow

argenx NV (ARGX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at 752 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow ARGX
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
-135 -125 42 438 408 752
109 8.6 8.9 13 15 17
131 103 128 111
-219 -178 -394 -129 -292 -296
0.0 0.3 0.0 0.8 0.0 1.0 0.0 5.2 0.0 0.9 0.0 3.0 3.9
-219 -514 -204 -10 829 -759
-12 -1.8 -20 -4.5
1,274 40 503 74 158 104
938 -611 325 586 1,405 93
-135 -125 41 433 407 749

LTM = last twelve months (sum of the four most recent quarters).

Data as of: August 14, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?